196
Articles
3.7K
Citations
2.7
avg. Impact Factor
32
h-index

Most Cited Articles of Division of Hematology/Oncology in 2017

TitleJournalYearCitations
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell DiseaseNew England Journal of Medicine2017381
Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAsAging2017112
Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cellsOncotarget201768
Leukemic Transformation in Myeloproliferative Neoplasms: A Literature Review on Risk, Characteristics, and OutcomeMayo Clinic Proceedings201757
Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasisAdvances in Biological Regulation201728
Contextual tumor suppressor function of T cell death-associated gene 8 (TDAG8) in hematological malignanciesJournal of Translational Medicine201710
Hemophagocytic lymphohistiocytosis (HLH) secondary to Ehrlichia chaffeensis with bone marrow involvementAnnals of Hematology20179
Impact of Primary Tumor Surgery in Stage IV Male Breast CancerClinical Breast Cancer20178
Kidney function of transfused children with sickle cell anemia: Baseline data from the TWiTCH study with comparison to non-transfused cohortsAmerican Journal of Hematology20175
Melanoma Screening: Thinking Beyond the GuidelinesMayo Clinic Proceedings20174
Vitamin D Deficiency in Adult Sickle Cell PatientsJournal of the National Medical Association20173
A Phenotype-Based RNAi Screening for Ras-ERK/MAPK Signaling-Associated Stem Cell Regulators in C. elegansMethods in Molecular Biology20173
Metastatic melanoma in a 95 years old patient responding to treatment with talimogene laherparepvec followed by nivolumabActa Oncológica20172
Cardiac Metastasis as Initial Site of Recurrence in Rectal CancerAmerican Journal of the Medical Sciences20171